Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC39A12 antisense RNA 1 (SLC39A12-AS1)
- Target
- SLC39A12-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), antisense RNA
01
Overview
SLC39A12 antisense RNA 1 (SLC39A12-AS1) is a long non-coding antisense RNA gene located adjacent to the *SLC39A12* gene, a zinc transporter. Like other antisense RNAs, SLC39A12-AS1 may regulate expression of its paired sense gene, potentially impacting transcription, RNA splicing, or chromatin structure, but its specific biological functions are currently not well-characterized. There is no established therapeutic relevance or drug interactions for this molecule; it primarily represents a genomic regulatory element whose dysregulation could theoretically contribute to disease via modulation of SLC39A12 expression.
- Other names
- SLC39A12-AS1SLC39A12 antisense RNA 1
02
Mechanism of action
Not applicable for drugs; however, antisense RNAs can influence mRNA stability, splicing, chromatin remodeling, or gene silencing via cis or trans mechanisms
03
Biological functions
Regulation of gene expression (generally affecting the sense gene, SLC39A12)May modulate transcription, RNA stability, splicing, or translation of the paired sense gene
04
Disease associations
No direct role established for SLC39A12-AS1 in specific diseases from available literatureBy analogy with other antisense lncRNAs, dysregulation could theoretically impact diseases where SLC39A12 or zinc homeostasis is involved (e.g., schizophrenia, based on the sense gene)
05
Safety considerations
None reported
06
Interacting drugs
None known
07
Biomarkers
None currently reported for SLC39A12-AS1
Beyond the preview
Go deeper on SLC39A12 antisense RNA 1 (SLC39A12-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SLC39A12 antisense RNA 1 (SLC39A12-AS1).